openPR Logo
Press release

Global rare disease genetic testing market was valued at $821.4 million in 2020 with a CAGR of 11.1% from 2021 to 2027

09-06-2021 11:23 AM CET | Health & Medicine

Press release from: INFINITY BUSINESS INSIGHTS

Global Rare Disease Genetic Testing Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)

Rare disease genetic testing screens all genes known to cause human disease. About 6000 genes are reported to be clinically relevant. The genetic tests are focused on analysis of specific genes, depending on which possible genetic diagnoses are suspected.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Get sample copy of this report @
https://www.infinitybusinessinsights.com/request_sample.php?id=457902

Top key players @ Fulgent Genetics Inc., CooperSurgical, Inc., Centogene, Quest Diagnostics Incorporated, Myriad Genetics, Inc., Genesis Genetics, Progenity, Inc., PreventionGenetics, Laboratory Corporation of America Holdings, Invitae Corporation, Sequenom, Counsyl, Inc., GeneDx, Connective Tissue Gene Tests, Bio-Reference Laboratories, ARUP Laboratories, Macrogen, Inc., Eurofins Scientific, PerkinElmer Genomics, 3billion, Inc., Ambry Genetics, Strand Life Sciences, OPKO Health, Inc., Color Genomics, Inc., and Baylor Genetics

Rising incidence of rare diseases is boosting the market growth. For instance, according to the World Health Organization (WHO), over 400 million people are living with one or more of 6,000 identified rare diseases around the world. Rare diseases affect 3.5% to 5.9% of the worldwide population. According to the Genetic and Rare Diseases Information Center, 1 in 10 American, which is 30 million people suffer for some kind of rare disease. 50% of people affected by rare diseases are children. According to the European Commission, approximately 5,000-8,000 distinct rare diseases affect 6% to 8% of the EU population, which is between 27 and 36 million people. In 2019, 70 million people in India are affected by rare diseases. According to the Australians Department of Health, around 8% of Australians, which is 2 million people live with a rare disease. About 80% of rare diseases are genetic in Australia. Further, innovative technologies for rare disease genetic testing is a key driving factor of the market.

Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Array Technology, PCR-based Testing, Sanger Sequencing, FISH, and Karyotyping is the technology segment of the market scope. By disease type the market is divided into Neurological Disorders, Immunological Disorders, Cancer, Hematology Diseases, Cardiovascular Disorders (CVDs), Endocrine & Metabolism Diseases, Musculoskeletal Disorders, Dermatology Disease, and Others. By specialty the market is further divided into Molecular Genetic Tests, Chromosomal Genetic Tests, and Biochemical Genetic Tests. By end user the global Rare Disease Genetic Testing market is divided as Research Laboratories & CROs, Diagnostic Laboratories, and Hospitals & Clinics. The report covers value of the global market by technology, disease type, specialty, and end user.

Based in technology, Whole Exome Sequencing (WES) has shown significant growth in 2020, owing to the increasing studies for whole exome sequencing (WES), rising awareness for rare disease genetic testing, and commercialization of service for whole exome sequencing (WES).

TABLE OF CONTENT:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecasts 2019-2025
14 Analyst’s Viewpoints/Conclusions
15 Appendix

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering the services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.

We attain particular and niche demand of the industry while stabilize the quantum of standard with specified time and trace crucial movement at both the domestic and universal levels. The particular products and services provided by Infinity Business Insights cover vital technological, scientific and economic developments in industrial, pharmaceutical and high technology companies.

Contact Us:
Amit J
Sales Coordinator
+1-518-300-3575
amit@infinitybusinessinsights.com
https://mobile.twitter.com/IBInsightsLLP
https://facebook.com/Infinity-Business-Insights-352172809160429
https://www.linkedin.com/company/infinity-business-insights/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global rare disease genetic testing market was valued at $821.4 million in 2020 with a CAGR of 11.1% from 2021 to 2027 here

News-ID: 2381978 • Views: 286

More Releases from INFINITY BUSINESS INSIGHTS

Global Plastic Bearing Market Growth Analysis, Latest Trends and Forecast till 2 …
The global Plastic Bearing market was valued at 53.04 Million USD in 2020 and will grow with a CAGR of 2.88% from 2021 to 2027. The research provides an in-depth analysis of the market. It accomplishes this through in-depth qualitative insights, historical data, and credible market size predictions. The forecasts in the paper were created utilising tried-and-true research methodology and assumptions. As a result, the research study relates to the
Automotive Trailer Market Significantly Stepping towards the Success Till 2027|W …
The global Automotive Trailer market was valued at 2148.62 Million USD in 2020 and will grow with a CAGR of 2.12% from 2021 to 2027. Automotive trailers are unpowered vehicles towed by a fueled vehicle with the assistance of a hitch. These trailers are utilized to move merchandise and products starting with one spot then onto the next. They are significantly utilized via freight organizations to move their merchandise either
Programmable Robots Market Recent Trends, Future Growth Analysis Forecasts 2027| …
The global Programmable Robots market was valued at 1625.8 Million USD in 2020 and will grow with a CAGR of 8.69% from 2021 to 2027. Programmable robots are kinds of programmed gadgets that ordinarily fill roles credited through controllers or indicated programs. These programmable automated units range from PC-controlled robots to basic remote controlled robots and further from complex robots like humanoids to basic wheeled robots. The market knowledge report is
Electronic Medical Records Market Players Focus on Executing Business Expansion …
Many government initiatives, such as encouraging physicians to use electronic health records, investing in training healthcare information technology workers, and establishing regional extension centres to provide technical and other advice, are fueling the growth of the Electronic Medical Records Market. In recent years, new expansion activities, product approvals, product launches, partnerships, and acquisitions have all had a positive impact on the market. Furthermore, due to increasing digitalization, there has been a

All 5 Releases


More Releases for Gene

Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Editing Technologies Market
Gene editing with engineered nucleases is anticipated to contribute significantly to the global life sciences industry. Gene editing provides application from studying gene functions in plants and animals to gene therapy in humans. Gene editing has more efficiency than many other methods in reverse genetics. Increased development of genetic engineering and increased funding in the field of gene editing is anticipated to drive the growth of the global gene editing